Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01150188 · ClinicalTrials.gov registry record · NA
Effects of Amino Acids on Regional Lipid Metabolism
A NA study of Hypertriglyceridemia, sponsored by University of Arkansas.
- Completed
- Registry status
- NA
- Development phase
- 125
- Enrollment target
- 1
- Study location
NCT01150188 is a NA study of Hypertriglyceridemia that has completed, run by University of Arkansas. The registered enrollment target is 125 participants, below the 171-participant average among 25 other Hypertriglyceridemia trials with a reported enrollment target (27% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01150188, a NA study of Hypertriglyceridemia, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
- 1
- Study location
Study Summary
Elevated fat level in blood is a risk factor for coronary heart disease, a major cause of death in America. The overall goal of this project is to test a novel treatment using nutrient (amino acid) supplementation against this condition in men and women, and to understand how this treatment works.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Amino acids
Study Locations (1)
Arkansas
- University of Arkansas for Medical Science, Reynolds Aging Institute - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2010-06 |
| Est. Completion | 2016-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01150188
The ClinicalTrials.gov registry entry for NCT01150188 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 171-participant average among 25 other Hypertriglyceridemia trials with a reported enrollment target (27% lower). The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hypertriglyceridemia appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01150188 reports 1 study location spanning 1 distinct geographic area - top geographies include Arkansas.
Frequently Asked Questions
What is clinical trial NCT01150188 about?
NCT01150188 is a clinical study titled "Effects of Amino Acids on Regional Lipid Metabolism". Elevated fat level in blood is a risk factor for coronary heart disease, a major cause of death in America. The overall goal of this project is to test a novel treatment using nutrient (amino acid) supplementation against this condition in men and women, and to understand how this treatment works.
What is the current status of trial NCT01150188?
This trial is currently completed. It is a NA study. The enrollment target is 125 participants. The study started on 2010-06. Estimated completion is 2016-08.
What conditions does trial NCT01150188 study?
This clinical trial studies the following conditions: Hypertriglyceridemia.
What interventions are being tested in trial NCT01150188?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Amino acids (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01150188?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01150188 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertriglyceridemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effects of Diet Interventions on Monocytes in Metabolic Syndrome
COMPLETED · NA
-
Novel Therapies for Metabolic Complications of Lipodystrophies
COMPLETED · NA
-
Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected Patients
COMPLETED · NA
-
Vascular and Lipid Effects of Omega-3 Fatty Acids in People With Moderately Elevated Triglycerides
COMPLETED · NA
-
Effects of Omega-3 Fatty Acids on Markers of Inflammation
COMPLETED · NA
-
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.